caret

Latest news

Filter by category:

FILTER: ALL CATEGORIESFilter by:

Latest news

07 Dec 2023

Charles River Laboratories joins CEPI's global vaccine assessment network
The global pharmaceutical company becomes the latest member of CEPI’s Centralised Laboratory Network created to standardise and speed up the development of epidemic and pandemic vaccines.

Read more

Read article

05 Dec 2023

CEPI partners with biotech Jurata Thin Film to create needle-free mRNA vaccines and improve access
Thermostable vaccine technology could end the need for frozen vaccine storage, expanding global access to mRNA LNP vaccines and supporting future pandemic response efforts.

Read more

28 Nov 2023

The road to even greater vaccine safety
Identifying underlying mechanisms for very rare but serious adverse events that might come after immunisation is key to improving vaccine safety

Read more

28 Nov 2023

CEPI, IVI and MRC Unit The Gambia partner to bolster clinical research capacity in West Africa to combat regional viral threats
CEPI-backed Research Preparedness Program West Africa aims to bolster regional clinical trial capacity and disease outbreak readiness.

Read more

15 Nov 2023

The Viral Most Wanted: The Arenavirus Family
The Arenavirus family includes some of the most lethal haemorrhagic fevers known. All its prime suspects can cause life-threatening disease and death.

Read more

10 Nov 2023

Accelerating access to the world’s first Chikungunya vaccine
As Valneva’s Chikungunya vaccine candidate gains FDA approval, CEPI’s CEO Dr Richard Hatchett outlines how CEPI/EU funding has been critical to accelerating access for endemic countries.

Read more

06 Nov 2023

The Netherlands bolsters world’s pandemic preparedness with increased CEPI funding 
Dutch Ministry of Health, Sports and Welfare provide additional EUR 14 million to improve global outbreak readiness 

Read more

06 Nov 2023

New experts appointed to join CEPI Scientific Advisory Committee
Nine new experts have been selected to join the committee

Read more

Read article

02 Nov 2023

CEPI and University of Oxford advance vaccine work against potentially deadly Arenaviruses
Up to US $25m will support early development of prototype vaccines against the Junín virus, while also looking to improve manufacturing speed and scale-up of ChAdOx technology.

Read more

30 Oct 2023

CEPI and Moderna harness mRNA technology to advance 100 Days Mission
New partnership will harness Moderna’s mRNA rapid-response platform, clinically validated during the COVID-19 pandemic, to accelerate epidemic and pandemic vaccine development.

Read more

27 Oct 2023

How prepared are we to face a future pandemic?
Joy Phumaphi, Co-Chair of The Global Preparedness Monitoring Board, writes about the 100 Days Mission and the journey ahead to get to a state of readiness needed to tackle a future pandemic.

Read more

©2023 CEPI. All rights reserved